These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19737947)

  • 1. Biomarkers in GIST: partly ready for prime-time use.
    Blanke CD
    Clin Cancer Res; 2009 Sep; 15(18):5603-5. PubMed ID: 19737947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of KIT in the management of patients with gastrointestinal stromal tumors.
    Hornick JL; Fletcher CD
    Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of gastrointestinal stromal tumor.
    D'Adamo D
    Adv Ther; 2009 Sep; 26(9):826-37. PubMed ID: 19802531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consensus on the medical treatment of gastrointestinal stromal tumors].
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
    [No Abstract]   [Full Text] [Related]  

  • 5. Sunitinib for imatinib-resistant GIST.
    Joensuu H
    Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
    [No Abstract]   [Full Text] [Related]  

  • 6. Perioperative treatment of gastrointestinal stromal tumors.
    Fernandes Gdos S; Blanke CD; Freitas D; Guedes R; Hoff PM
    Oncology (Williston Park); 2009 Jan; 23(1):54-61. PubMed ID: 19283922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnostic and predictive role of kit (CD117)].
    Dirnhofer S; Zimpfer A; Went P
    Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview.
    Sartini S; Dario B; Morelli M; Da Settimo F; La Motta C
    Curr Med Chem; 2011; 18(19):2893-903. PubMed ID: 21651490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
    Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
    J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
    Shen L
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
    [No Abstract]   [Full Text] [Related]  

  • 11. Hits and misses in targeting pediatric cancers.
    Bernstein ML
    Pediatr Blood Cancer; 2009 Jul; 52(7):751-2. PubMed ID: 19185009
    [No Abstract]   [Full Text] [Related]  

  • 12. Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells.
    Dong Y; Liang C; Zhang B; Ma J; He X; Chen S; Zhang X; Chen W
    Cancer Lett; 2015 May; 361(1):137-46. PubMed ID: 25737303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis, imatinib dose, and benefit of sunitinib in GIST: knowing the genotype.
    Judson IR
    J Clin Oncol; 2008 Nov; 26(33):5322-5. PubMed ID: 18955449
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting ETV1 in gastrointestinal stromal tumors: tripping the circuit breaker in GIST?
    Duensing A
    Cancer Discov; 2015 Mar; 5(3):231-3. PubMed ID: 25749973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors.
    Szucs Z; Thway K; Fisher C; Bulusu R; Constantinidou A; Benson C; van der Graaf WT; Jones RL
    Future Oncol; 2017 Jan; 13(2):185-194. PubMed ID: 27600625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib: from rational design to clinical efficacy.
    Chow LQ; Eckhardt SG
    J Clin Oncol; 2007 Mar; 25(7):884-96. PubMed ID: 17327610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
    Renouf DJ; Wilson L; Blanke CD
    Clin Cancer Res; 2009 Jun; 15(12):3908-11. PubMed ID: 19509180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.
    Nannini M; Ravegnini G; Angelini S; Astolfi A; Biasco G; Pantaleo MA
    Epigenomics; 2015; 7(6):1033-49. PubMed ID: 26447534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathobiology of gastrointestinal stromal sarcomas.
    Corless CL; Heinrich MC
    Annu Rev Pathol; 2008; 3():557-86. PubMed ID: 18039140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.